Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,450 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Is Nike losing its spark in performance running? This article dives into whether nike lost edge performance and what ...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
The NRC granted TerraPower a construction permit for a sodium-cooled reactor in Wyoming, marking a watershed for adva...
BitGo is lining up a $2 billion IPO and seeking an OCC national bank charter, while facing competition from Morgan St...
As March 2026 unfolds, traders weigh the best webull alternatives competitors. Here’s a clear, up-to-date look at the...
NVIDIA has built a powerful moat around AI hardware and software. This deep dive explains a compelling growth catalys...
The International Energy Agency announced a historic emergency stock release of 400 million barrels, aiming to cool e...
In Washington, governors from both parties pressed for a sweeping review of the nation’s workforce policy amid AI-dri...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
Pi Network’s PI token fell about 30% within 24 hours after Kraken’s listing, renewing questions about the project’s r...
Tokyo signals dispatching ships to the Middle East would face steep political and legal barriers, as Tokyo weighs all...